Worth type autosomal dominant osteosclerosis

From WikiMD's WELLNESSPEDIA

Other Names: Osteosclerosis, autosomal dominant; Endosteal hyperostosis, autosomal dominant; Osteosclerosis, autosomal dominant, Worth type; Worth syndrome; Endosteal hyperostosis, Worth type; Autosomal dominant osteosclerosis, Worth type; Hyperostosis corticalis generalisata, benign form of Worth with torus palatinus

Worth type autosomal dominant osteosclerosis is a sclerozing bone disorder characterized by generalized skeletal densification, particularly of the cranial vault and tubular long bones, which is not associated to an increased risk of fracture.

Epidemiology[edit]

The syndrome has been described in less than 10 families.

Cause[edit]

The syndrome is due to a mutation in the LRP5 gene that leads to increased bone formation.

Inheritance

Autosomal dominant pattern, a 50/50 chance.

Transmission is autosomal dominant.

Signs and symptoms[edit]

Craniofacial anomalies develop during adolescence and include a prominent forehead, wide and deep mandibles, wide nasal root, taurus palatinus and increased gonial angle.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

  • Abnormal cortical bone morphology
  • Abnormality of the ribs(Rib abnormalities)
  • Clavicular sclerosis(Increased bone density in collarbone)
  • Craniofacial hyperostosis(Excessive bone growth of the skull and face)
  • Diaphyseal thickening(Thickening of shaft or central part of long bones)
  • Generalized osteosclerosis
  • Torus palatinus

30%-79% of people have these symptoms

  • Abnormal form of the vertebral bodies
  • Sclerotic vertebral body

5%-29% of people have these symptoms

  • Facial palsy(Bell's palsy)
  • Mandibular prognathia(Big lower jaw)
  • Nystagmus(Involuntary, rapid, rhythmic eye movements)
  • Sensorineural hearing impairment


NIH genetic and rare disease info[edit]

Worth type autosomal dominant osteosclerosis is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.